Konings A W, Rasker J J
Strahlentherapie. 1978 Jan;154(1):63-70.
57Co-bleomycin appears to be one of the best tumor detecting agents at the moment. The localization within the cells is not yet known. This preclinical investigation had the aim to study the subcellular distribution of 57Co-bleomycin in liver, spleen and tumors of rats and mice. Mice with transplanted lymphosarcoma and osteosarcoma were used and rats with transplanted rhabdomyosarcoma. The concentration of 57Co-bleomycin was 2 to 10 times higher in the tumors as compared to the (normal) liver. This accumulation property was not found with the control substance: 57CoCl2. The highest radioactivity of 57Co-bleomycin (cpm/mg protein) was observed in subcellular fractions containing mitocohndria and lysosomes. After treatment of these fractions with hypertonic solutions it could be shown that enzymes of the mitochondrial matrix remained inside the vesicles under conditions of almost complete release of 57Co-bleomycin. Half of the lysosomal enzyme acid phosphatase was released too. From these experiments it is concluded that 57Co-bleomycin is preferentially localized in heavy secondary lysomes which are more fragile than the lighter lysosomes in the cells.
57钴-博来霉素似乎是目前最好的肿瘤检测剂之一。其在细胞内的定位尚不清楚。这项临床前研究旨在研究57钴-博来霉素在大鼠和小鼠的肝脏、脾脏及肿瘤中的亚细胞分布。使用了移植有淋巴肉瘤和骨肉瘤的小鼠以及移植有横纹肌肉瘤的大鼠。与(正常)肝脏相比,肿瘤中57钴-博来霉素的浓度高2至10倍。对照物质57氯化钴未发现这种积累特性。在含有线粒体和溶酶体的亚细胞组分中观察到57钴-博来霉素的放射性最高(每分钟计数/毫克蛋白质)。用高渗溶液处理这些组分后发现,在57钴-博来霉素几乎完全释放的情况下,线粒体基质中的酶仍保留在囊泡内。溶酶体酶酸性磷酸酶也有一半被释放。从这些实验得出结论,57钴-博来霉素优先定位于重的次级溶酶体中,这些溶酶体比细胞中较轻的溶酶体更脆弱。